SCHEMBL12435121

SCHEMBL12435121

O=C(NC1CCN(c2nnc(-c3ccccc3)c3ccccc23)CC1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 5/20 0.55
PAK1 Q13153 2/20 0.55
KDR P35968 5/20 0.52
HTT P42858 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
DRD4 P21917 2/20 0.51
CKS1B P61024 1/20 0.51
SKP1 P63208 1/20 0.51
SKP2 Q13309 1/20 0.51
DRD2 P14416 1/20 0.51
GAA P10253 1/20 0.50
SLC6A5 Q9Y345 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1268247 0.99 SMO (0.55) SMOPAK1KDRHTTNPSR1
SCHEMBL12435117 0.93 SMO (0.54) SMOPAK1KDRHTTNPSR1
Hydrochloric Acid SCHEMBL2205497 0.92 SMO (0.53) SMOPAK1KDRHTTNPSR1
SCHEMBL12435127 0.90 SMO (0.61) SMOKDRHTTNPSR1CKS1B
SCHEMBL4257505 0.90 SMO (0.57) SMOKDRHTTNPSR1MEN1
SCHEMBL12435101 0.85 SMO (0.65) SMOPAK1KDRHTTNPSR1
Hydrochloric Acid SCHEMBL1268376 0.84 SMO (0.64) SMOPAK1KDRHTTNPSR1
SCHEMBL27809326 0.82 CKS1B (0.53) SMOKDRHTTNPSR1CKS1B
Hydrochloric Acid SCHEMBL1268477 0.80 NPSR1 (0.54) SMOKDRHTTNPSR1MEN1
Isophthalic Acid SCHEMBL28790907 0.79 SMO (0.57) SMOKDRHTTNPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7981892-B2 Disubstituted phthalazine hedgehog pathway antagonists ELI LILLY AND COMPANY (US) 2011-07-19 US disclosed
US-7981892-B2 Disubstituted phthalazine hedgehog pathway antagonists ELI LILLY AND COMPANY (US) 2011-07-19 US disclosed
US-20110046143-A1 DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-02-24 US disclosed
US-20110046143-A1 DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046143-A1 DISUBSTITUTED PHTHALAZINE HEDGEHOG PATHWAY ANTAGONISTS SHH, GLI1, SMO SMO 3/4885PAK1 585/4885KDR 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.